HealthNotableConfirmed
9.2
EU Commission approves weight-loss medication for obesity treatment
Die PresseLO·EU·3 days ago
HealthEmergingLow
1.9
Youtuber reports 30-day experience with experimental weight-loss drug retatrutide
A social media influencer documented a 30-day trial of retatrutide, an experimental GLP-1/GIP/glucagon receptor agonist currently in clinical development. The report lacks clinical oversight and highlights the risks of self-administering unapproved pharmaceutical compounds.
Score Breakdown
Mosaic Score1.9
Confidence0.5
Significance0.1
Source credibility0.2
Intelligence Tags
Related signals
8 foundHealthNotableSingle-sourceDeveloping
5.6
GLP-1 receptor agonist adoption trends and clinical implications in US healthcare
Al Jazeera·US·1 day ago
HealthSingle-source
2.1
São Paulo Court Denies Public Funding for Wegovy Weight-Loss Medication
Valor Econômico·BR·2 days ago
HealthSingle-sourceDeveloping
2.0
Molecure receives recommendation to continue Phase II trial for OATD-01 in pulmonary sarcoidosis
ParkietLO·PL·2 days ago
HealthNotableConfirmedDeveloping
10.0
Argentine Pharmacists Oppose Deregulation of Over-the-Counter Drug Sales
PerfilLO·AR·2 days ago
HealthNotableCorroboratingDeveloping
10.0
Semaglutide debate in South Africa highlights systemic public trust deficit in healthcare institutions
Mail & GuardianLO·ZA·3 days ago
HealthNotableConfirmedDeveloping
10.0
FDA issues recall for cetirizine batches over cross-contamination risk
La República (Peru)LO·US·3 days ago
PoliticsNotableConfirmedDeveloping
10.0
New US Congress introduces 70 legislative proposals including tax and energy reforms
El EspectadorLO·US·3 days ago